The top-funded private digital health companies in the U.S. tended to look at healthy populations in their studies published in peer-reviewed journals.
Do digital tools fail to show impact in high-risk, high-cost populations?
The top-funded private digital health companies in the U.S. tended to look at healthy populations in their studies published in peer-reviewed journals.